Profile
| Metric | Value |
|---|---|
| Full Name | Cellebrite DI Ltd. |
| Ticker | NASDAQ: CLBT |
| Exchange | NASDAQ |
| Sector | Technology |
| Industry | Software Infrastructure |
| Country | Israel |
| IPO | |
| Indexes | Not included |
| Website | cellebrite.com |
| Employees | 1,167 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $17.15 | |
| Price, 1D Change | -1.49% | |
| Market Cap | $4B | |
| - | ||
| PE Ratio | 55.92 | |
| Beta | 0.70 | |
| Revenue | $401M | |
| Revenue, 1Y Change | +23.41% | |
| EPS | -$1.35 | |
| EPS, 1Y Change | -216.76% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.35 | |
| EPS Estimate | $0.51 | |
| EPS Est. Change | +137.68% | |
| Revenue | $401.20M | |
| Revenue Estimate | $472.92M | |
| Revenue Est. Change | +17.88% | |
| Current Price | $17.15 | |
| Price Target | - | $24.00 |
| Price Tgt. Change | - | +39.94% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.25 | -$0.43 | -270.60% | |
| $0.43 | -$1.35 | -415.73% | |
| $0.51 | N/A | +137.68% | |
| $0.55 | N/A | +140.59% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $317.67M | $325.11M | +2.34% | |
| $399.39M | $401.20M | +0.45% | |
| $472.92M | N/A | +17.88% | |
| $554.50M | N/A | +38.21% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -25.37% | |
| Price, 3Y | +290.66% | |
| Market Cap, 1Y | -22.21% | |
| Market Cap, 3Y | +394.81% | |
| Revenue, 1Y | +23.41% | |
| Revenue, 3Y | +62.93% | |
| EPS, 1Y | -216.76% | |
| EPS, 3Y | -405.66% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $17.15 | |
| SMA 200 | $17.20 | |
| SMA 200 vs Price | +0.31% | |
| SMA 50 | $17.77 | |
| SMA 50 vs Price | +3.62% | |
| Beta | 0.70 | |
| ATR | $0.55 | |
| 14-Day RSI | 40.35 | |
| 10-Day Volatility | 27.40% | |
| 1-Year Volatility | 45.42% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $401.20M | |
| EPS | -$1.35 | |
| Gross Profit | $338.61M | |
| Gross Margin | 84.40% | |
| Operating Profit | $56.91M | |
| Operating Margin | 14.18% | |
| Net Income | -$283.01M | |
| Net Margin | -70.54% | |
| EBITDA | $67.51M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.00 | |
| Current Ratio | 1.92 | |
| Quick Ratio | 1.89 | |
| Interest Coverage | 1,962.28 | |
| F-Score | 5 | |
| Altman Z-Score | 7.96 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 55.92 | |
| PS Ratio | 9.20 | |
| PB Ratio | 9.37 | |
| EV/EBITDA | 49.65 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $336.02M | |
| Cash & Equivalents | $191.66M | |
| Total Assets | $696.57M | |
| Current Assets | $567.59M | |
| Total Liabilities | $360.55M | |
| Current Liabilities | $295.50M | |
| Total Debt | $10.97M | |
| Short Term Debt | $4.13M | |
| Accounts Payable | $11.08M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $344.30M | |
| Operating Expenses | $281.70M | |
| Cost Of Goods Sold | $62.59M | |
| SG&A | $183.29M | |
| D&A | $10.61M | |
| Interest Expense | $29.00K | |
| Income Tax | $7.02M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $132.17M | |
| CFI | -$149.47M | |
| CFF | $20.65M | |
| Capex | $10.61M | |
| Free Cash Flow | $121.56M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Needham | → | |
| Lake Street | → | |
| JP Morgan | → | |
| B of A Securities | → | |
| JP Morgan | → | |
| Lake Street | → | |
| Needham | → | |
| JP Morgan | → | |
| Needham | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with CLBT
Data Sources & References
- CLBT Official Website www.cellebrite.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1854587/000121390025109216/0001213900-25-109216-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1854587/000162828025013334/0001628280-25-013334-index.htm
- CLBT Profile on Yahoo Finance finance.yahoo.com/quote/CLBT
- CLBT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/clbt
FAQ
What is the ticker symbol for Cellebrite DI Ltd.?
The ticker symbol for Cellebrite DI Ltd. is NASDAQ:CLBT
Does Cellebrite DI Ltd. pay dividends?
No, Cellebrite DI Ltd. does not pay dividends
What sector is Cellebrite DI Ltd. in?
Cellebrite DI Ltd. is in the Technology sector
What industry is Cellebrite DI Ltd. in?
Cellebrite DI Ltd. is in the Software Infrastructure industry
What country is Cellebrite DI Ltd. based in?
Cellebrite DI Ltd. is headquartered in Israel
When did Cellebrite DI Ltd. go public?
Cellebrite DI Ltd. initial public offering (IPO) was on November 6, 2020
Is Cellebrite DI Ltd. in the S&P 500?
No, Cellebrite DI Ltd. is not included in the S&P 500 index
Is Cellebrite DI Ltd. in the NASDAQ 100?
No, Cellebrite DI Ltd. is not included in the NASDAQ 100 index
Is Cellebrite DI Ltd. in the Dow Jones?
No, Cellebrite DI Ltd. is not included in the Dow Jones index
When was Cellebrite DI Ltd. last earnings report?
Cellebrite DI Ltd.'s most recent earnings report was on November 12, 2025
When does Cellebrite DI Ltd. report earnings?
The next expected earnings date for Cellebrite DI Ltd. is February 19, 2026